Table 2.

Time on Concurrent Drug Therapies in Group 1 Patients in the First 6 Months Post transplant

	Group 1 – Time on Concurrent Drug Therapies (%)
Therapy	Patient 1	Patient 2	Patient 3	Patient 4
ACEi	60	0	0	0
Anti-CMV	0	66.7	64.3	27.8
Maintenance corticosteroids	0	0	0	100
CCB	70	33.3	35.7	61.1

Concurrent drug therapies of ACEi, anti-CMV therapy, maintenance corticosteroids, and dihydropyridine CCBs were recorded at time of tacrolimus trough measurement. Time on a concurrent drug therapy was defined as the percentage of time the patient reported taking a medication in each drug category. ACEi = angiotensin-converting-enzyme inhibitors; CCB = calcium channel blocker; CMV = cytomegalovirus.